Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Target Dose (Monotherapy/Combination): The common target dose used in major clinical trials is 2.4 mg per week
The one honest exception: TB-500 works partly by mass-action, so a higher local concentration in the brief window before it disperses is at least plausible
Their combined anti-inflammatory actions has been seen to create a more favorable environment for tissue repair
However, BPC-157 is not approved for human use by any regulatory agency, and its safety remains largely unproven
US$ 25.01
US$ 24.66
US$ 20.22
US$ 24.03
US$ 29.67
US$ 27.09
US$ 21.17
US$ 25.45
US$ 21.45
US$ 26.21
US$ 28.92
